Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for Methylphenidate-Induced Appetite Suppression in ADHD
NCT01940978Phase 4Completed
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cyproheptadine in anorexia nervosa (AN) (3 arms). Primary endpoint: Appetite and Dietary Assessment Tool at 12 weeks. Started Mar 2014; status: completed.
02
Drugs
cyproheptadine
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT01940978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01940978.